Trial Profile
Efficacy and Safety of Inhaled Prandial Insulin Compared to Metformin Plus Glimepiride in Type 2 Diabetes.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Glimepiride; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms iINHALE-7
- Sponsors Novo Nordisk
- 05 Oct 2021 Trial has been completed in france (global end of the trial 2008-03-04) as per European Clinical Trials Database record.
- 13 Oct 2009 Actual initiation date changed from May 2007 to Apr 2007 as reported by ClinicalTrials.gov.
- 13 Oct 2009 Actual end date changed from Mar 2008 to Apr 2008 added as reported by ClinicalTrials.gov.